Sun Pharma’s US innovative drug sales surpass generics for the first time

Sun Pharma's U.S. innovative medicine sales have surpassed generics for the first time, driven by key products like Ilumya and Cequa. The launch of Leqselvi for alopecia has been well-received, with further growth anticipated from upcoming launches like Unloxcyt. This marks a significant shift in the company's revenue streams.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/U6reqMC
via IFTTT